Correlation Between Praxis Precision and Theriva Biologics

Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Praxis Precision Medicines and Theriva Biologics, you can compare the effects of market volatilities on Praxis Precision and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Theriva Biologics.

Diversification Opportunities for Praxis Precision and Theriva Biologics

0.04

Correlation Coefficient

Praxis Precision  Theriva Biologics

Significant diversification

The 3 months correlation between Praxis and Theriva is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Praxis Precision i.e., Praxis Precision and Theriva Biologics go up and down completely randomly.

Pair Corralation between Praxis Precision and Theriva Biologics

Given the investment horizon of 90 days Praxis Precision is expected to generate 3.69 times less return on investment than Theriva Biologics. But when comparing it to its historical volatility, Praxis Precision Medicines is 3.29 times less risky than Theriva Biologics. It trades about 0.09 of its potential returns per unit of risk. Theriva Biologics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  129.00  in Theriva Biologics on October 11, 2024 and sell it today you would earn a total of  18.00  from holding Theriva Biologics or generate 13.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Praxis Precision Medicines  vs.  Theriva Biologics

Praxis Precision Med

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point.

Theriva Biologics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Theriva Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Theriva Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Praxis Precision and Theriva Biologics

The main advantage of trading using opposite Praxis Precision and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.

The idea behind Praxis Precision Medicines and Theriva Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.